Health
New On Robinhood
Medical
Guardant Health
$79.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$79.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$6.06 (-7.12%) Today
-$0.01 (-0.01%) After Hours
Why Robinhood?
You can buy or sell GH and other stocks, options, ETFs, and crypto commission-free!
About
Guardant Health, Inc. Common Stock, also called Guardant Health, is a precision oncology company, which engages in provision of precision oncology testing and development services. Read More It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.
Employees
454
Headquarters
Redwood City, California
Founded
2012
Market Cap
7.30B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
723.58K
High Today
$85.00
Low Today
$78.35
Open Price
$84.93
Volume
750.87K
52 Week High
$106.58
52 Week Low
$27.04
Collections
Health
New On Robinhood
Medical
Cancer Prevention
2018 IPO
US
North America
News
The Motley FoolMar 21
Better Buy: Illumina vs. Guardant Health
Thanks to scientific breakthroughs, we're living in an age of miracles, according to David Gardner, cofounder of The Motley Fool.
Guru FocusMar 19
Guardant Health Inc (GH) Files 10-K for the Fiscal Year Ended on December 31, 2018
Guardant Health Inc (NASDAQ:GH) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Guardant Health Inc has a market cap of $7.83 billion; its shares were traded at around $91.23 . For the last quarter Guardant Health Inc reported a revenue of $32.9 million, compared with the revenue of $11.13 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $90.6 million, an increase of 81.9% from last year. The reported loss per diluted sh...
MarketWatchMar 13
Guardant Health Inc.
Guardant Health Inc. Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA. (See Full Profile)...
Price Paid on Robinhood
18% Higher
Right Now
52 Week Low
$27.04
Average Price Paid
$66.76
52 Week High
$106.58
Earnings
-$1.94
-$1.39
-$0.85
-$0.30
Q3 2018
Q4 2018
Estimated
-$0.35 per share
Actual
-$0.30 per share